P. Hjelmström

发表

Different HLA‐DR‐DO haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type‐16 seropositive and seronegative Swedish women

F. Wiklund, J. Dillner, G. Hallmans, 1996, International journal of cancer.

Lack of association of CCR2-64I and CCR5-Delta 32 with type 1 diabetes and latent autoimmune diabetes in adults.

P. Nyren, L. Nikitina-Zake, M. Ghaderi, 2003, Human immunology.

What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine

A. Benyamina, G. Brousse, F. Vorspan, 2019, Expert opinion on drug delivery.

Kinetics and Cellular Origin of Cytokines in the Central Nervous System: Insight into Mechanisms of Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis1

A. Juedes, P. Hjelmström, Annie L. Neild, 2000, The Journal of Immunology.

Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome.

R. Jonsson, K. Brokstad, M. Jonsson, 2003, Arthritis and rheumatism.

Lymphoid tissue homing chemokines are expressed in chronic inflammation.

J. Fjell, T. Nakagawa, T. Nakagawa, 2000, The American journal of pathology.

Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines

P. Hjelmström, 2001, Journal of leukocyte biology.

Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease.

P. Nyren, F. Santeusanio, A. Sirsjö, 2004, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis

I. Kockum, M. Landin-Olsson, R. Pirskanen, 1996, Journal of Neuroimmunology.

Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis.

I. Kockum, M. Landin-Olsson, R. Pirskanen, 1995, Autoimmunity.

Localization of the tetrodotoxin‐resistant sodium channel NaN in nociceptors

S. Dib-Hajj, S. Waxman, J. Fjell, 2000, Neuroreport.

TAP polymorphisms in Swedish myasthenia gravis patients.

I. Kockum, M. Landin-Olsson, R. Pirskanen, 1997, Tissue antigens.

Polymorphism in tumor necrosis factor genes associated with myasthenia gravis

C. Peacock, R. Pirskanen, R. Giscombe, 1998, Journal of Neuroimmunology.

Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder

G. Brousse, B. Trojak, P. Hjelmström, 2021, Patient preference and adherence.

MICA gene polymorphism and the risk to develop cervical intraepithelial neoplasia.

F. Wiklund, J. Dillner, G. Hallmans, 1999, Human immunology.

Autoimmune Encephalomyelitis Glycoprotein-Induced Experimental Mechanisms of Myelin Oligodendrocyte the Central Nervous System : Insight into Kinetics and Cellular Origin of Cytokines in

A. Juedes, P. Hjelmström, Annie L. Neild, 1999 .

Tumor Necrosis Factor a-11 and DR 15-DQ 6 ( B * 0602 ) Haplotype Increase the Risk for Cervical Intraepithelial Neoplasia in Human Papillomavirus 16 Seropositive Women in Northern Sweden 1

F. Wiklund, J. Dillner, G. Hallmans, 2000 .

M. Ramstedt, P. Hjelmström, G. Ågren, 2022, Drug and alcohol dependence.

S. Bremberg, P. Hjelmström, A. Fugelstad, 2020, Addiction.

Med-Sci 2013 Poster Presenter Abstracts 1. A NOVEL BUPRENORPHINE/NALOXONE TABLET FORMULATION FOR THE TREATMENT OF OPIOID DEPENDENCE

C. Hendy, P. Hjelmström, Martin Jönsson, 2013 .

Med-Sci 2013 Poster Presenter Abstracts

Hendy, P. Hjelmström, Martin Jönsson, 2013 .

Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data

F. Tiberg, P. Hjelmström, Elin Banke Nordbeck, 2020, Drug development and industrial pharmacy.

Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling

T. Lybrand, J. Penzotti, C. Sanjeevi, 1998, Journal of Neuroimmunology.

Increased CD8+ central memory T cells in patients with multiple sclerosis

P. Hjelmström, Xu-guang Gao, Guang-Zhi Liu, 2007, Multiple sclerosis.

Increased Soluble 4‐1BB Ligand (4‐1BBL) Levels in Peripheral Blood of Patients with Multiple Sclerosis

K. Kostulas, J. Hillert, V. Karrenbauer, 2006, Scandinavian journal of immunology.

Lymphotoxin-alpha deficiency completely protects C57BL/6 mice from developing clinical experimental autoimmune myasthenia gravis

P. Christadoss, E. Goluszko, P. Hjelmström, 2001, Journal of Neuroimmunology.

Molecular Mechanisms of MHC Associations with Myasthenia Gravis

C. Sanjeevi, P. Hjelmström, 2000 .

Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis

J. Hillert, P. Hjelmström, T. Masterman, 2004, Journal of Neuroimmunology.

A Critical Role for Lymphotoxin in Experimental Allergic Encephalomyelitis

P. Hjelmström, Nancy H. Ruddle, N. Ruddle, 1997, The Journal of experimental medicine.

Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden.

F. Wiklund, J. Dillner, G. Hallmans, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Polymorphisms in IL-1β and IL-1 receptor antagonist genes are associated with myasthenia gravis

R. Pirskanen, A. Lefvert, Deren Huang, 1998, Journal of Neuroimmunology.

HLA-DQ associations and T-cell receptor V-gene usage in peripheral blood of Swedish myasthenia gravis patients.

R. Pirskanen, R. Giscombe, C. Sanjeevi, 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Expression of the B Cell‐Attracting Chemokine CXCL13 in the Target Organ and Autoantibody Production in Ectopic Lymphoid Tissue in the Chronic Inflammatory Disease Sjögren's Syndrome

M. Wahren-Herlenius, S. Salomonsson, P. Hjelmström, 2002, Scandinavian journal of immunology.

Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis.

R. Pirskanen, A. Lefvert, P. Hjelmström, 1998, Journal of neuroimmunology.

Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine

P. Haber, D. Lubman, A. Dunlop, 2021, JAMA network open.

Cytokines and antibodies in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis.

A. Juedes, P. Hjelmström, N. Ruddle, 1998, Research in immunology.

Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone.

G. Brousse, B. Trojak, P. Hjelmström, 2021, Drug and alcohol dependence.

B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.

J. Fjell, A. Juedes, P. Hjelmström, 1998, Journal of immunology.